OCUL
Ocular Therapeutix, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +10.0% ·
Aktienfluss +5.5% ·
neue Nettopositionen +9.1%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | -8 | 115.87M | $1.14B | +4 | −12 |
| Q1 2026 | 101 | +4 | 114.41M | $983.07M | +11 | −8 |
| Q4 2025 | 96 | +1 | 115.21M | $1.40B | +2 | — |
| Q3 2025 | 18 | 0 | 82.57M | $965.26M | +1 | −1 |
| Q2 2025 | 15 | +1 | 57.50M | $533.65M | +1 | — |
| Q1 2025 | 11 | 0 | 20.34M | $149.08M | +1 | −1 |
| Q4 2024 | 11 | +1 | 19.58M | $167.25M | +2 | −1 |
| Q3 2024 | 9 | +1 | 15.07M | $131.15M | +1 | — |
| Q2 2024 | 8 | — | 16.30M | $111.49M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 4.46M | +4.6% | $38.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 4.46M | +4.6% | $38.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Adage Capital Partners ✦ | 3.60M | -4.0% | $30.74M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passiv) | 3.49M | — | $29.80M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 3.24M | -1.1% | $27.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 3.24M | -1.1% | $27.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Point72 Asset Management ✦ | 2.94M | +43.9% | $25.07M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 638.96K | -34.6% | $5.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 638.96K | -34.6% | $5.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 467.35K | +1.0% | $3.99M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 447.24K | Neu | $3.82M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 252.94K | +21.9% | $2.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 31.42K | Neu | $268,318 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 26.28K | +50.3% | $224,423 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 26.28K | +50.3% | $224,423 | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Millennium Management | $3.82M | 0.0% |
| D. E. Shaw & Co. | $268,318 | 0.0% |
Ausgestiegen
| Marshall Wace | $763,365 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 266 Inhaber, 206.22M Anteile, $1.70B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.